Westfield Capital Management Co. LP Purchases 509,724 Shares of Masimo Corporation $MASI

Westfield Capital Management Co. LP raised its position in shares of Masimo Corporation (NASDAQ:MASI) by 75.9% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,181,203 shares of the medical equipment provider’s stock after buying an additional 509,724 shares during the quarter. Masimo comprises about 0.8% of Westfield Capital Management Co. LP’s investment portfolio, making the stock its 26th largest holding. Westfield Capital Management Co. LP’s holdings in Masimo were worth $198,702,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of MASI. Nordea Investment Management AB boosted its stake in Masimo by 21.6% in the second quarter. Nordea Investment Management AB now owns 31,868 shares of the medical equipment provider’s stock valued at $5,330,000 after acquiring an additional 5,659 shares in the last quarter. Strs Ohio purchased a new stake in shares of Masimo during the 1st quarter valued at $6,686,000. Swedbank AB purchased a new stake in shares of Masimo during the 1st quarter valued at $12,645,000. Harbor Capital Advisors Inc. acquired a new stake in shares of Masimo in the 2nd quarter worth $4,443,000. Finally, Intech Investment Management LLC grew its stake in Masimo by 26.8% during the 1st quarter. Intech Investment Management LLC now owns 32,494 shares of the medical equipment provider’s stock worth $5,414,000 after buying an additional 6,872 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Price Performance

Shares of NASDAQ MASI opened at $140.94 on Thursday. Masimo Corporation has a 52 week low of $133.70 and a 52 week high of $194.88. The business’s 50 day moving average price is $145.62 and its 200 day moving average price is $152.98. The company has a quick ratio of 1.61, a current ratio of 2.14 and a debt-to-equity ratio of 0.57. The firm has a market cap of $7.57 billion, a P/E ratio of -16.54 and a beta of 1.28.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Thursday, June 20th. The medical equipment provider reported $1.42 earnings per share (EPS) for the quarter. The company had revenue of $617.00 million during the quarter. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. On average, sell-side analysts expect that Masimo Corporation will post 4.1 earnings per share for the current year.

Analyst Ratings Changes

MASI has been the subject of a number of research analyst reports. Zacks Research cut Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Piper Sandler increased their price objective on shares of Masimo from $200.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 6th. Wall Street Zen upgraded shares of Masimo from a “hold” rating to a “buy” rating in a research note on Tuesday, October 14th. BTIG Research reissued a “buy” rating and set a $198.00 target price on shares of Masimo in a research report on Wednesday, November 5th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Masimo in a report on Wednesday, October 8th. Five research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $188.67.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.